Opportunity Information: Apply for CDC RFA DP14 1404
Apply for CDC RFA DP14 1404
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "State Based Perinatal Quality Collaboratives" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.946 Cooperative Agreements to Support State Based Safe Motherhood and Infant Health Initiative Programs.
- This funding opportunity was created on May 9, 2014 and posted on May 9, 2014.
- Applicants must submit their applications by Jun 23, 2014 Dates 1. Letter of Intent (LOI) Deadline N/A 2. Application Deadline 06/23/2014, 1159 p.m. U.S. Eastern Standard Time, on www.grants.gov 3. Informational conference call for potential applicants 06/05/2014, 100 p.m. U.S. Eastern Day Light Savings Time (EDT). 4. Call in number 1 877 324 1604, Participant Code 2920385.
- The funding agency has allocated a total of $3,600,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- A. Eligibility Information 1. Eligible Applicants State Health Departments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. 2. Special Eligibility Requirements For Module A, eligibility is limited to the State Health Departments (or their Bona Fide Agent) that are not currently funded under CDC RFA DP11 1110, and that have demonstrated participation in an ongoing Perinatal Quality Collaborative, with an existing statewide collaborative project with established pediatric/neonatology and obstetric/perinatology leadership. For Module B, eligibility is limited to existing Perinatal Quality Collaborative Grantee states currently funded under CDC RFA DP11 1110. Applicants eligible to apply for this module are Leland Stanford Junior University (acting as a bona fide agent of the California Department of Health), Health Research, Inc. (acting as a bona fide agent of the New York State Department of Health, and Ohio Department of Health. 3. Justification for Less than Maximum Competition Competition for this funding will be limited to State Health Departments or their Bona Fide Agents who have demonstrated participation in an ongoing Perinatal Quality Collaborative, with an existing statewide collaborative project with established pediatric/neonatology and obstetric/perinatology leadership (Module A). States that are currently funded under CDC RFA DP11 1110 are not eligible for Module A. State Health Departments or their Bona Fide Agents are designated as registration areas for vital statistics and are uniquely qualified to perform the programmatic activities for this project. Moreover, they have the ability and authority to obtain population based information from core data sets (such as birth and death files), which is crucial for the successful functioning of a statewide collaborative. Although most of the work of the Collaborative occurs in health care and academic institutions, basing the Collaborative in the State Department of Health allows for institutionalizing the efforts of the Collaborative as a core public health function and allows for oversight and accountability of public funds. Moreover, as the seat of statewide public health practice, basing the Collaborative in the State Health Department furthers the notion that quality statewide improvement in maternal and neonatal health care has the potential to improve traditional indicators of public health. Finally, the potential for sustainable statewide quality improvement activities is more likely to be realized when they begin as state based initiatives rather than initiatives begun by individuals or individual institutions. For Module B, eligibility is further limited to existing State based Perinatal Quality Collaborative grantee states funded under CDC RFA DP11 1110. Applicants eligible to apply for this module are Leland Stanford Junior University (acting as a bona fide agent of the California Department of Health), Health Research, Inc. (acting as a bona fide agent of the New York State Department of Health), and Ohio Department of Health. These states are uniquely qualified to build upon their three years of experience during the current funding opportunity, expanding their statewide collaborative activities and making improvements in the collection and quality of the data used for quality improvement projects.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity titled "State Based Perinatal Quality Collaboratives" (Funding Opportunity Number CDC RFA DP14-1404) is a discretionary health grant offered as a cooperative agreement. Its central aim is to strengthen state-based Perinatal Quality Collaboratives (PQCs) by improving their ability to collect timely, high-quality data and then use that data to deliver practical feedback to participating facilities. The overarching intent is quality improvement in perinatal care, meaning better systems and practices around pregnancy, delivery, and newborn care, with an emphasis on using reliable data to drive measurable improvements.
At its core, the program is designed to help PQCs do three things better and at larger scale. First, it focuses on data: enhancing how PQCs capture, manage, and analyze information so they can generate faster and more accurate performance feedback for hospitals and other member facilities. Second, it emphasizes broader participation: increasing the proportion of hospitals within a state that are actively involved in the collaborative, so quality improvement work is not limited to a small subset of institutions. Third, it supports expanding the scope of improvement projects: moving beyond a narrow set of issues to address a wider range of neonatal and maternal health challenges, allowing collaboratives to tackle multiple drivers of morbidity and mortality across the perinatal period.
This opportunity was posted May 9, 2014, with applications due June 23, 2014 by 11:59 p.m. U.S. Eastern Time through Grants.gov, and it was archived July 23, 2014. CDC scheduled an informational conference call for potential applicants on June 5, 2014 at 1:00 p.m. Eastern Daylight Time, with a call-in number (1-877-324-1604) and participant code (2920385). There was no letter of intent requirement. The total estimated funding was $3.6 million, with an expected six awards. The listed award ceiling was $200,000, with no cost sharing or matching requirement.
Eligibility is tightly defined and revolves around state public health authority and existing PQC infrastructure, reflecting CDCs emphasis on statewide reach, access to population-based data, and long-term sustainability. Eligible applicants are State Health Departments or their Bona Fide Agents, which can include U.S. jurisdictions and territories such as the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. A Bona Fide Agent, as described in the notice, is an organization officially designated by the state to apply on the states behalf.
The announcement outlines two separate eligibility tracks, described as Module A and Module B. Module A is intended for State Health Departments (or their Bona Fide Agents) that are not already funded under a prior CDC award (CDC RFA DP11-1110) and that can demonstrate active participation in an ongoing PQC. For Module A applicants, CDC expects an existing statewide collaborative project with established leadership in both pediatrics/neonatology and obstetrics/perinatology, signaling that the collaborative is already functioning and has clinical credibility and governance in place. Module B is reserved for a small set of existing PQC grantee states already funded under CDC RFA DP11-1110, effectively allowing those established programs to continue and expand. The opportunity explicitly names the eligible Module B applicants as Leland Stanford Junior University (serving as bona fide agent for the California Department of Health), Health Research, Inc. (serving as bona fide agent for the New York State Department of Health), and the Ohio Department of Health.
CDC also provides a rationale for limiting competition. The agency emphasizes that State Health Departments are the designated registration areas for vital statistics and are uniquely positioned to access and use core population-based datasets such as birth and death records. This access is portrayed as crucial for a functioning statewide quality collaborative because it enables measurement, benchmarking, and tracking outcomes across the state, not just within a handful of facilities. CDC further notes that while much of the improvement work occurs within healthcare systems and academic partners, anchoring the PQC in the State Health Department helps institutionalize perinatal quality improvement as a public health function, strengthens oversight and accountability for public funds, and improves the odds of long-term sustainability by making the effort state-based rather than dependent on a single institution or individual champions.
From a practical standpoint, applicants were being funded to reinforce the operating backbone of a statewide PQC: data quality and timeliness, feedback loops to participating hospitals, expanded hospital engagement, and broader project portfolios addressing maternal and neonatal health concerns. Because the instrument is a cooperative agreement, recipients should expect substantial involvement from CDC in program implementation, such as collaboration on strategies, performance expectations, or technical guidance, rather than a hands-off relationship typical of some grants.
For administrative or technical issues accessing the full announcement, CDC directed applicants to the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), reachable by phone at 770-488-2700 or by email at pgotim@cdc.gov. The CFDA listing associated with the program is 93.946, identified as "Cooperative Agreements to Support State Based Safe Motherhood and Infant Health Initiative Programs."
Frequently Asked Questions (FAQs): CDC "State Based Perinatal Quality Collaboratives" (CDC RFA DP14-1404)
What is the name and funding opportunity number for this CDC grant?
The opportunity is titled "State Based Perinatal Quality Collaboratives" and the Funding Opportunity Number is CDC RFA DP14-1404.
What type of funding instrument is this?
This is a discretionary health grant offered as a cooperative agreement, meaning recipients should expect substantial CDC involvement during implementation (for example, collaboration on strategies, performance expectations, and technical guidance).
What is the central purpose of this funding opportunity?
The central aim is to strengthen state-based Perinatal Quality Collaboratives (PQCs) by improving their ability to collect timely, high-quality data and use that data to deliver practical performance feedback to participating facilities, supporting measurable quality improvement in perinatal care (pregnancy, delivery, and newborn care).
What are the main focus areas CDC expects PQCs to improve?
The program is designed to help PQCs improve in three core areas: (1) data capacity (capturing, managing, analyzing, and producing timely and accurate feedback), (2) participation (increasing the proportion of hospitals in the state that are active members), and (3) project scope (expanding quality improvement projects to address a wider range of neonatal and maternal health challenges).
How does this opportunity define "quality improvement" in perinatal care?
Within the context provided, quality improvement refers to improving systems and practices around pregnancy, delivery, and newborn care, with an emphasis on using reliable, timely data to drive measurable improvements and provide actionable feedback to facilities.
Who is eligible to apply?
Eligible applicants are State Health Departments or their Bona Fide Agents. Eligibility also includes U.S. jurisdictions and territories listed in the opportunity, including the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
What is a "Bona Fide Agent" in this announcement?
A Bona Fide Agent is an organization officially designated by the state to apply on the state's behalf.
What are Module A and Module B, and how do they affect eligibility?
The announcement includes two eligibility tracks. Module A is for State Health Departments (or their Bona Fide Agents) that are not already funded under prior CDC award CDC RFA DP11-1110 and that can demonstrate active participation in an ongoing PQC. Module B is limited to a small set of existing PQC grantee states already funded under CDC RFA DP11-1110, allowing those established programs to continue and expand.
What additional expectations are described for Module A applicants?
For Module A, CDC expects an existing statewide collaborative project with established leadership in pediatrics/neonatology and obstetrics/perinatology, indicating the PQC is already functioning with clinical credibility and governance.
Who is explicitly eligible under Module B?
The eligible Module B applicants are explicitly named as: Leland Stanford Junior University (serving as bona fide agent for the California Department of Health), Health Research, Inc. (serving as bona fide agent for the New York State Department of Health), and the Ohio Department of Health.
Why did CDC limit eligibility primarily to State Health Departments (or their Bona Fide Agents)?
CDC states that State Health Departments are the designated registration areas for vital statistics and are uniquely positioned to access and use population-based datasets such as birth and death records. This statewide access supports measurement, benchmarking, and tracking outcomes across the state. CDC also indicates that anchoring PQCs in the State Health Department can institutionalize perinatal quality improvement as a public health function, strengthen oversight and accountability for public funds, and support long-term sustainability.
What kinds of data does CDC highlight as important for statewide PQCs?
CDC specifically points to core population-based datasets such as birth and death records (vital statistics) as crucial resources for measuring, benchmarking, and tracking outcomes statewide.
What is the estimated total funding amount for this opportunity?
The total estimated funding is $3.6 million.
How many awards did CDC expect to make?
CDC expected to make six awards.
What is the award ceiling?
The listed award ceiling is $200,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
When was the opportunity posted, and when were applications due?
The opportunity was posted on May 9, 2014. Applications were due June 23, 2014 by 11:59 p.m. U.S. Eastern Time.
How were applications submitted?
Applications were to be submitted through Grants.gov by the stated deadline.
Was a letter of intent required?
No. The opportunity states there was no letter of intent requirement.
When was the opportunity archived?
The opportunity was archived on July 23, 2014.
Did CDC host an informational call for potential applicants?
Yes. CDC scheduled an informational conference call for June 5, 2014 at 1:00 p.m. Eastern Daylight Time.
What were the call-in details for the informational conference call?
The call-in number provided was 1-877-324-1604 and the participant code was 2920385.
What kinds of activities were applicants being funded to strengthen within a PQC?
Based on the description provided, funding supported strengthening the operating backbone of statewide PQCs, including improving data quality and timeliness, creating stronger feedback loops to participating hospitals, expanding hospital engagement statewide, and broadening the portfolio of maternal and neonatal quality improvement projects.
Where should applicants have directed administrative or technical questions about accessing the full announcement?
CDC directed applicants to the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS). The phone number listed is 770-488-2700 and the email is pgotim@cdc.gov.
What CFDA program is associated with this opportunity?
The CFDA listing associated with the program is 93.946, identified as "Cooperative Agreements to Support State Based Safe Motherhood and Infant Health Initiative Programs."
Browse more opportunities from the same category: Health
Next opportunity: Supporting Civic Engagement and National Dialogue through Independent Palestinian Media
Previous opportunity: Civil Society Capacity Building for Advocacy and Response to the HIV/AIDS Epidemic Among Key Populations in India under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP14 1404
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP14 1404) also looked into and applied for these:
| Funding Opportunity |
|---|
| Immunization and Vaccines for Children Program Apply for CDC RFA IP13 1301PPHF15 Funding Number: CDC RFA IP13 1301PPHF15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $33,000,000 |
| Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01) Apply for PA 14 218 Funding Number: PA 14 218 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Center for Integrative Medicine in Primary Care Program Apply for HRSA 14 123 Funding Number: HRSA 14 123 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| CONNECTING KIDS TO COVERAGE Outreach and Enrollment Grants Focused on Increasing Enrollment of American Indian/Alaska Native Children Apply for CMS 1Z0 14 001 Funding Number: CMS 1Z0 14 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $500,000 |
| NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01) Apply for PA 14 217 Funding Number: PA 14 217 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| B Cell Help Immunology Program for AIDS Vaccine Strategies (R01) Apply for PA 14 216 Funding Number: PA 14 216 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Vaccine Vector Host Interactions Understanding the Biology and Immunology (R21) Apply for PA 14 214 Funding Number: PA 14 214 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| HIV Vaccine Vector Host Interactions Understanding the Biology and Immunology (R01) Apply for PA 14 215 Funding Number: PA 14 215 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Renewal Awards of SBIR Phase IIB Grants for Brain and Behavior Tools (R44) Apply for PA 14 219 Funding Number: PA 14 219 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Preventing Injuries and Violence by Informing State Strategies Apply for CDC RFA CE14 1403 Funding Number: CDC RFA CE14 1403 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01) Apply for PAR 14 220 Funding Number: PAR 14 220 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Confirmatory Efficacy Clinical Trials of Non Pharmacological Interventions for Mental Disorders (R01) Apply for RFA MH 15 340 Funding Number: RFA MH 15 340 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Local Nongovernmental Partnerships for Sustained Country Leadership in Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1413 Funding Number: CDC RFA GH14 1413 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| FY14 Partnerships to Increase Coverage in Communities Initiative Apply for MP CPI 14 003 Funding Number: MP CPI 14 003 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $250,000 |
| Service Area Competition Additional Area (SAC AA) Cincinnati, Ohio Apply for HRSA 14 146 Funding Number: HRSA 14 146 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition National Primate Research Centers (P51) Apply for PAR 14 226 Funding Number: PAR 14 226 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multiple Approaches to Increase Awareness and Support among Young Women Diagnosed with Breast Cancer Apply for CDC RFA DP14 1408 Funding Number: CDC RFA DP14 1408 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Evidence Based Tele Emergency Network Grant Program Apply for HRSA 14 138 Funding Number: HRSA 14 138 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIH Science Education Partnership Award (SEPA) (R25) Apply for PAR 14 228 Funding Number: PAR 14 228 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Assessment of Elastomeric Respirators in Healthcare Environments (R21) Apply for RFA OH 14 009 Funding Number: RFA OH 14 009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP14 1404", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.